Synthesis and Cholinesterase Inhibitory Activity of N-Phosphorylated / N-Tiophosphorylated Tacrine.

BACKGROUND Alzheimer's disease (AD) is progressive and irreversible neurodegenerative disorder. Current pharmacotherapy is not able to stop progression of the disease and can only improve cognitive functions. Therefore, new drugs are being sought that will slow down or slow the development of the disease. OBJECTIVE Novel phosphorus and thiophosphorus tacrine derivatives 7-14 were designed, synthesized and their biological activity and molecular modeling was investigated as a new potential anti-Alzheimer's disease (AD) agents. METHOD 9-Chlorotacrine was treated with propane-1,3-diamine in the presence of sodium iodide to yield N1-(1,2,3,4-tetrahydroacridin-9-yl)propane-1,3-diamine 6. Finally, it was treated with corresponding acid ester or thioester to give phosphorus or thiophosphorus tacrine derivative 7-14. All of the obtained final structures were characterized by 1H NMR, 13C NMR, 31P NMR and MS. RESULTS The results of the docking studies showed that the newly designed phosphorus and thiophosphorus tacrine analogs, theoretically possess AChE and BChE-binding ability. Kinetic study showed that 8 and 12 in the series proved to be more potent electric eel AChE (eeAChE) and human (hAChE) inhibitors than tacrine, where 8 inhibited eeAChE three times more than referenced drug. The highest BChE inhibition revealed 11 and 13. The most active compounds against eeAChE, hAChE and BChE showed mixed type of inhibition. CONCLUSION All new synthesized compound exhibited lower toxicity against neuroblastoma cell line (SH-SY5Y) in comparison with tacrine. Two analogues in the series, 7 and 9, demonstrated lack of cytotoxicity against hepatocellular cells (hepG2).

[1]  I. Inkielewicz-Stępniak,et al.  Therapeutic Potential of Multifunctional Tacrine Analogues , 2019, Current neuropharmacology.

[2]  Xuehua Zheng,et al.  Synthesis and Evaluation of Novel Ligustrazine Derivatives as Multi-Targeted Inhibitors for the Treatment of Alzheimer's Disease. , 2018 .

[3]  Krajňáková Lucia,et al.  Intracellular distribution of new tacrine analogues as a potential cause of their cytotoxicity against human neuroblastoma cells SH-SY5Y , 2018, Medicinal Chemistry Research.

[4]  R. V. Omkumar,et al.  Novel tacrine derivatives exhibiting improved acetylcholinesterase inhibition: Design, synthesis and biological evaluation. , 2017, European journal of medicinal chemistry.

[5]  B. Winblad,et al.  The worldwide costs of dementia 2015 and comparisons with 2010 , 2017, Alzheimer's & Dementia.

[6]  Yuqiong Pei,et al.  Identification of 4-aminoquinoline core for the design of new cholinesterase inhibitors , 2016, PeerJ.

[7]  Mateusz Daśko,et al.  Synthesis and steroid sulfatase inhibitory activities of N-phosphorylated 3-(4-aminophenyl)-coumarin-7-O-sulfamates , 2016 .

[8]  Mateusz Daśko,et al.  Selected organophosphorus compounds with biological activity. Applications in medicine , 2016 .

[9]  V. Andrisano,et al.  Novel Tacrine-Benzofuran Hybrids as Potent Multitarget-Directed Ligands for the Treatment of Alzheimer's Disease: Design, Synthesis, Biological Evaluation, and X-ray Crystallography. , 2016, Journal of medicinal chemistry.

[10]  Masayoshi Takeuchi,et al.  Glyceraldehyde caused Alzheimer’s disease-like alterations in diagnostic marker levels in SH-SY5Y human neuroblastoma cells , 2015, Scientific Reports.

[11]  Xingshu Li,et al.  Tacrine–propargylamine derivatives with improved acetylcholinesterase inhibitory activity and lower hepatotoxicity as a potential lead compound for the treatment of Alzheimer’s disease , 2015, Journal of enzyme inhibition and medicinal chemistry.

[12]  V. Andrisano,et al.  Multitarget drug design strategy: quinone-tacrine hybrids designed to block amyloid-β aggregation and to exert anticholinesterase and antioxidant effects. , 2014, Journal of medicinal chemistry.

[13]  Om Silakari,et al.  Multifunctional compounds: smart molecules for multifactorial diseases. , 2014, European journal of medicinal chemistry.

[14]  R. Armstrong,et al.  What causes alzheimer's disease? , 2013, Folia neuropathologica.

[15]  C. Ballard,et al.  A review of butyrylcholinesterase as a therapeutic target in the treatment of Alzheimer's disease. , 2013, The primary care companion for CNS disorders.

[16]  Lei Li,et al.  Multifunctional mercapto-tacrine derivatives for treatment of age-related neurodegenerative diseases. , 2012, Journal of medicinal chemistry.

[17]  V. Andrisano,et al.  Cystamine-tacrine dimer: A new multi-target-directed ligand as potential therapeutic agent for Alzheimer’s disease treatment , 2012, Neuropharmacology.

[18]  V. Andrisano,et al.  Chemical and Pharmacological Studies on Enantiomerically Pure p‐Methoxytacripyrines, Promising Multi‐Target‐Directed Ligands for the Treatment of Alzheimer’s Disease , 2011, ChemMedChem.

[19]  M. Markowicz,et al.  Synthesis and biological activity of derivatives of tetrahydroacridine as acetylcholinesterase inhibitors. , 2011, Bioorganic chemistry.

[20]  M. Mezei,et al.  Molecular docking: a powerful approach for structure-based drug discovery. , 2011, Current computer-aided drug design.

[21]  M. Gütschow,et al.  Kinetics of inhibition of acetylcholinesterase in the presence of acetonitrile , 2009, The FEBS journal.

[22]  Vincenza Andrisano,et al.  Rational approach to discover multipotent anti-Alzheimer drugs. , 2005, Journal of medicinal chemistry.

[23]  C. Cotman,et al.  Evolution in the Conceptualization of Dementia and Alzheimer’s Disease: Greco-Roman Period to the 1960s , 1998, Neurobiology of Aging.

[24]  D. Casciano,et al.  HepG2 cells: an in vitro model for P450-dependent metabolism of acetaminophen. , 1993, Biochemical and biophysical research communications.

[25]  G. Mulder,et al.  Hepatotoxicity of tetrahydroaminoacridine in isolated rat hepatocytes: effect of glutathione and vitamin E. , 1988, Biochemical pharmacology.

[26]  K. Courtney,et al.  A new and rapid colorimetric determination of acetylcholinesterase activity. , 1961, Biochemical pharmacology.

[27]  D. Langford,et al.  Considerations for the use of SH-SY5Y neuroblastoma cells in neurobiology. , 2013, Methods in molecular biology.